Pfizer Inc (NYSE:PFE) announced it has submitted pediatric data for Lipitor® (atorvastatin) to the European Medicines Agency (EMEA). Pfizer has also developed a new chewable form of Lipitor, including a pediatric-appropriate 5 mg dose, which is part of this submission.

The rest is here: 
Pfizer Submits New Pediatric Data For Lipitor(R) (Atorvastatin) To The European Medicines Agency (EMEA)

>

Tags: Breast Cancer, Diabetes, Disease, genetics, health-articles, health-news, healthcare-news, living, medical, medical-news, medicine, syndrome

This entry was posted on Wednesday, November 18th, 2009 at 6:00 pm and is filed under Cholesterol. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.